NCT05840991

Brief Summary

A prospective, multicenter, non-inferiority, randomized controlled trial is designed to evaluate the effect after short-term compression therapy following thermal ablation of varicose veins. Patients will be randomly assigned in a 1:1 ratio to one of the following treatments: (A) elastic bandage for 48h or (B) elastic bandage for the first 24h and then a compression full-length stocking (23-32mm Hg) for 1 week. The two groups will be compared on several variables, including target vein occlusion rate at 3 months (primary outcome indicator) , as well as pain, quality of life, clinical severity of varicose veins, postoperative complications, time to return to normal work, and compliance.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
360

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 17, 2023

Completed
16 days until next milestone

First Posted

Study publicly available on registry

May 3, 2023

Completed
19 days until next milestone

Study Start

First participant enrolled

May 22, 2023

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

June 5, 2023

Status Verified

June 1, 2023

Enrollment Period

6 months

First QC Date

April 17, 2023

Last Update Submit

June 1, 2023

Conditions

Keywords

Varicose veinsThermal ablationCompression therapyTargeted vein occlusion rateRandomized controlled trial

Outcome Measures

Primary Outcomes (1)

  • Target vein occlusion rate as assessed by duplex ultrasound scan

    The primary outcome of the study is target vein occlusion rate at 3 months assessed with duplex ultrasound scan. Recanalisation will be defined by a segment of vein≥5cm. Target vein occlusion rate = Number of target venous closure cases in the group/total number of cases in the group

    3 months post-op

Secondary Outcomes (6)

  • Pain score as assessed by VAS

    Baseline, 1 week post-op, 3 months post-op

  • Quality of life score as assessed by AVVQ

    Baseline, 1 week post-op, 3 months post-op

  • Venous clinical severity score as assessed by VCSS

    Baseline, 1 week post-op, 3 months post-op

  • Postoperative complications

    1 week post-op, 3 months post-op

  • Time to return to normal work

    1 week post-op, 3 months post-op

  • +1 more secondary outcomes

Study Arms (2)

Short-term compression group

EXPERIMENTAL

Patients randomised to group A will be provided with bandages to wear for 48 hours only

Device: elastic bandage

Long-term compression group

ACTIVE COMPARATOR

Patients randomised to group B will be asked to wear bandages for the first 24h and then a Class 2 compression full-length stocking (23-32mm Hg) for 1 week

Device: elastic bandageDevice: compression stocking

Interventions

3M™ Coban™ elastic bandage

Long-term compression groupShort-term compression group

Class 2 compression full-length stocking (23-32mm Hg)

Long-term compression group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with primary unilateral lower limb saphenous varicose veins aged 18 to 80 years
  • Patients with CEAP classification of C2-C4 stage
  • mm≤diameter of the main trunk of the saphenous vein in the thigh segment ≤15mm
  • Agree to participate in this study and voluntarily sign the informed consent form

You may not qualify if:

  • Patients who have difficulty tolerating surgery
  • The main trunk of the saphenous vein is extremely twisted or tightly attached to the skin
  • Previous history of ipsilateral varicose vein surgery in the lower extremity
  • Combined deep vein thrombosis in the affected lower extremity or previous deep vein thrombosis in the affected lower extremity
  • Uncorrectable coagulation dysfunction or significant blood abnormalities with significant bleeding tendency (platelets ≤ 30\*10\^9/L)
  • Acute thrombosis in the saphenous vein
  • Combination of the affected lower extremity lower extremity atherosclerotic occlusive disease who
  • Ankle-brachial index ABI \< 0.6 and/or absolute ankle pressure \< 60 mmHg
  • Patients who cannot wear elastic stockings or are allergic to elastic bandages or elastic stockings
  • Patients during pregnancy or lactation
  • Previous history of pulmonary embolism
  • Participating in clinical trials of other drugs or devices
  • Other patients deemed unsuitable for this study by the investigator

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Fourth Affiliated Hospital Zhejiang University School of Medicine

Yiwu, Zhejiang Procince, 310000, China

RECRUITING

Related Publications (1)

  • Tang M, Jiang W, Hong J, Li L, Shang D, Zhao Y, Liu Z, Qi M, Jin M, Zhu Y. Effect of short-term compression therapy after thermal ablation for varicose veins: study protocol for a prospective, multicenter, non-inferiority, randomized controlled trial. Trials. 2023 Oct 12;24(1):669. doi: 10.1186/s13063-023-07609-1.

MeSH Terms

Conditions

Varicose Veins

Interventions

Compression BandagesStockings, Compression

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

BandagesEquipment and Supplies

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 17, 2023

First Posted

May 3, 2023

Study Start

May 22, 2023

Primary Completion

November 30, 2023

Study Completion

December 31, 2023

Last Updated

June 5, 2023

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will not share

Locations